Photoactive and Luminescent Transition Metal Complexes as Anticancer Agents: A Guiding Light in the Search for New and Improved Cancer Treatments
Cancer continues to be responsible for the deaths of more than 9 million people worldwide each year. Current treatment options are diverse, but low success rates, particularly for those with late-stage cancers, continue to be a problem for clinicians and their patients. The effort by researchers glo...
Main Authors: | Brondwyn S. McGhie, Janice R. Aldrich-Wright |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/3/578 |
Similar Items
-
Development and Application of Ruthenium(II) and Iridium(III) Based Complexes for Anion Sensing
by: Ambreen Rashid, et al.
Published: (2023-01-01) -
Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
by: Joanna Masternak, et al.
Published: (2020-08-01) -
Anticancer Activity of Half-Sandwich Ru, Rh and Ir Complexes with Chrysin Derived Ligands: Strong Effect of the Side Chain in the Ligand and Influence of the Metal
by: Ana R. Rubio, et al.
Published: (2021-09-01) -
Synthesis and Characterisation of Platinum(II) Diaminocyclohexane Complexes with Pyridine Derivatives as Anticancer Agents
by: Brondwyn S. McGhie, et al.
Published: (2023-12-01) -
Features of Luminescent Properties of Alginate Aerogels with Rare Earth Elements as Photoactive Cross-Linking Agents
by: Vladislav Kaplin, et al.
Published: (2022-09-01)